WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity,foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间:2025-07-11 直链:westvacpharma.com
Fitzgerald、Meridian、HyTest、Medix、BiosPacific、Calbioreagents、Scantibodies、BBI、Bioventix、DIAsource、Proliant、CerTest、日本特殊免疫研究所等等品牌代理。产品涵盖免疫诊断全领域,主要应用于心肌类、炎症类、肿瘤类、甲状腺性腺类、传染病类、优生优育类等,同时提供与之配套的质控和去激素基质。
更新时间:2025-07-11 直链:www.bjbiobridge.com
瑞博奥(广州)生物科技股份有限公司提供专业的多因子检测,抗体芯片,Antibodies,Array,AssayKits,ElisaKits,FlowCytometry,ProteinsandPeptides,RayBiotech。
更新时间:2025-07-09 直链:www.raybiotech.com.cn
WuhanUSCNBusinessCo.,Ltd.mainlyfocusedonmarketingoflifescienceassayreagents,SuchasProteins,AntibodiesandImmunoassayKits(ELISAKit,CLIAKit,ChipKit)
更新时间:2025-07-07 直链:uscnk.com
Proteintechmatchesits’customers’dedicationtoresearchbyprovidinghigh-qualityantibodies,ELISAkitsandproteinsthatcontributetoreproducibleresults.Learnmorehere.
更新时间:2025-06-24 直链:www.ptgcn.com